I
10.37
-0.30 (-2.81%)
| Previous Close | 10.67 |
| Open | 10.52 |
| Volume | 78,322 |
| Avg. Volume (3M) | 867,857 |
| Market Cap | 1,260,572,032 |
| Price / Sales | 7.08 |
| Price / Book | 2.06 |
| 52 Weeks Range | |
| Earnings Date | 17 Nov 2025 |
| Profit Margin | -15.54% |
| Operating Margin (TTM) | -190.37% |
| Diluted EPS (TTM) | -0.200 |
| Quarterly Revenue Growth (YOY) | -38.60% |
| Total Debt/Equity (MRQ) | 3.43% |
| Current Ratio (MRQ) | 10.28 |
| Operating Cash Flow (TTM) | -159.63 M |
| Levered Free Cash Flow (TTM) | -117.80 M |
| Return on Assets (TTM) | -5.84% |
| Return on Equity (TTM) | -4.78% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Immatics N.V. | Bullish | Mixed |
AIStockmoo Score
-1.0
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 0.5 |
| Average | -1.00 |
|
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 22.85% |
| % Held by Institutions | 79.42% |
| 52 Weeks Range | ||
| Median | 16.00 (54.29%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Guggenheim | 18 Sep 2025 | 16.00 (54.29%) | Buy | 6.61 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |